- OverviewPress tab for submenu items
TCS is here to make a difference through technology.
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
Overview
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- OverviewPress tab for submenu items
We’re in it for good, driving positive change for the benefit of all.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
-
About Us
- OverviewPress tab for submenu items
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- OverviewPress tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- OverviewPress tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
-
News alerts
-
Analyst recognition
Recent recognitions
View all -
Events
Upcoming events
08 Nov 2024 TCS BaNCS at CorpActions 2024, LondonView all29 Oct 2024 TCS at OpenText World 2024 -
Media kit
- OverviewPress tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
Top Results
Showing
10
01 - 07
You have these already downloaded
We have sent you a copy of the report to your email again.
Industries
Life Sciences
This will open an overlay
Patient-centered Care Models Taking Center Stage in Life Sciences
Read how patient-centric care models and pharma innovation are ushering new trends in life sciences to improve patient outcomes and enrich lives.
Related Insights
Know how regulatory teams can overcome hurdles like unclear IVD/CDx regulatory path and lengthy drug approval time to offer personalized and comprehensive care.
Blog
16 Sep 2024
Read about technology in clinical trials and how AI for drug discovery can reduce the cost of running a drug R&D process and improve trial efficiency.
Blog
13 Dec 2022
Our regulatory affairs services encompass regulatory authoring, RIM, regulatory intelligence, and more to deliver high-quality submissions to health authorities.
Solution
23 Jul 2024
Healthcare
This will open an overlay
Patient-centered Care: Health and Wellness Redefined
TCS’ research and innovation enable healthcare firms to focus on patients’ health and wellness, and provide high-quality personalized, value-based care.
Related Insights
Nitin Kumar, VP of Healthcare at TCS, shares how sensitive healthcare data from wearable devices can be compromised and what is TCS doing to solve it.
Article
30 Oct 2024
Read how digital healthcare technologies can help reduce the economic burden of Alzheimer's and dementia and redefine chronic disease management.
White Paper
24 Aug 2022
AI-led business architecture enhances healthcare affordability, patient experience, and others, guiding TCS's approach to integrating AI in healthcare.
White Paper
19 Sep 2024
Solutions
TCS TwinX™
This will open an overlay
Enterprise Digital Twin Platform for Risk-Free Business Experiments
TCS TwinX platform helps organizations to build their enterprise digital twins by modelling key enterprise entities for a seamless customer journey. Learn how.
Related Insights
TCS and TM Forum are developing a Decision Intelligence framework to help communication service providers make faster, more accurate decisions and improve CX.
Blog
26 Oct 2023
Future technology will be based on digital twin technology. Learn how digital twin platforms can create positive transformation in both business and society.
Blog
15 May 2023
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
Join us at the life sciences event to learn how AI and generative AI can accelerate next-gen clinical R&D and enhance patient safety. Register now for the event.
Events
07 Aug 2024
Engage with our experts at the World Drug Safety Congress Americas 2024 to learn about AI in pharmacovigilance and our TCS ADD™ Safety platform. Join us now.
Events
09 Sep 2024
TCS’ End-To-End Offering for Decentralized Trials, TCS ADD™ Connected Clinical Trials Cited as a Key Strength
Press Releases
25 Oct 2022
An interview with Debashis Ghosh, President, Business Group Head, TCS
The confluence of technology and science is transforming the healthcare industry. The use of AI-powered digital twin technology has the potential to revolutionize healthcare by delivering precise and reproducible care without intrusion or risk. The shift toward in-silico methods, including digital twins and Generative AI (GenAI), is revolutionizing how we approach drug research and development.
GenAI facilitates knowledge synthesis, molecule design, and clinical trials, enhancing efficiency and accuracy. GenAI's impact is evident in expedited market entry, cost-effectiveness, and personalized treatment, paving the way for a more responsive, affordable, and tailored healthcare system in line with the emerging trends in precision medicine.
Streamlined processes, accurate drug design, and support for knowledge synthesis have accelerated the journey from discovery to development. GenAI is becoming a foundational technology for organizations which can be applied broadly across the healthcare value chain. TCS is investing strategically in GenAI and contributing to client success in healthcare research and development.
Debashis Ghosh
President, Life Sciences, Healthcare, Energy, Resources, and Utilities, TCS
GenAI holds immense potential to transform drug discovery from trial-and-error to a more predictable, efficient, and personalized approach. It can significantly reduce the time and cost of bringing new drugs to market by making clinical trial outcomes more predictable.
Item 1 of 3
Related reading
Swipe Left
Swipe Right
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our experts
©2024 TATA Consultancy Services Limited
©2024 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?